| Mon 12 Mar 2012, 9:00 | | MDC - Mediclinic International Limited - Disclosure of changes in beneficial |
|
MDC
MDC
MDC - Mediclinic International Limited - Disclosure of changes in beneficial
interest
Mediclinic International Limited
(Incorporated in the Republic of South Africa)
(Registration number: 1983/010725/06)
ISIN: ZAE000074142
Share Code: MDC
("Mediclinic" or "the company")
DISCLOSURE OF CHANGES IN BENEFICIAL INTEREST
In accordance with the JSE Limited Listings Requirements and section 122(1) of
the Companies Act, 71 of 2008, as amended, shareholders are advised of the
following:
Coronation Asset Management (Pty) Ltd notified the company on 9 March 2012 that
accounts under its management have increased its holding of Mediclinic ordinary
shares from 4.47% to 8.45%.
In addition, The International Hospitals Network Partnership ("IHN"), an
associate of Trilantic Capital Partners, also informed the company on 9 March
2012 that it disposed of 26.0 million Mediclinic ordinary shares representing
39.86% of its shareholding in Mediclinic, reducing its interest from 10.00% to
6.01% in the company.
Sanjay Nandi, a principal of Trilantic Capital Partners, commented on the
transaction: "IHN retains a significant interest in the business of Mediclinic
and therefore exposure to a sector and company that we like."
Stellenbosch
12 March 2012
Mediclinic Offices, Strand Road, Stellenbosch 7600, South Africa
PO Box 456, Stellenbosch 7599, South Africa
Tel +27 (0)21 809 6500
Fax +27 (0)21 886 4037
Ethics Line: 0800 005 316
Website: www.mediclinic.com
Merchant Bank and sponsor
RAND MERCHANT BANK (a division of FirstRand Bank Limited)
Date: 12/03/2012 09:00:09 Produced by the JSE SENS Department.
The SENS service is an information dissemination service administered by the
JSE Limited (`JSE`). The JSE does not, whether expressly, tacitly or
implicitly, represent, warrant or in any way guarantee the truth, accuracy or
completeness of the information published on SENS. The JSE, their officers,
employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature,
howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
